Transcript Quarterly Performance Update

Council of
Governors Meeting
Elaine Hobson
Chief Operating Officer
January 2010, Item 7
Relates to Domain 1 (C4a)
and Domain 5 (C18, C19)
Key Targets
1
Hospital Acquired Infections
Performance Indicators
Incidence of Clostridium difficile
MON01, CQC16
Incidence of MRSA
MON02, CQC15
Current
Year to Date
Position
Position
Nov 2009
Risk
Rating
Target
2009-10
Low
183
(112)
13
66
Med
18
(9)
0
4
-0
7
Ju
n07
Au
g07
Oc
t-0
7
De
c-0
7
Fe
b08
Ap
r-0
8
Ju
n08
Au
g08
Oc
t-0
8
De
c-0
8
Fe
b09
Ap
r-0
9
Ju
n09
Au
g09
Oc
t-0
9
Ap
r
Key Targets
1
Hospital Acquired Infections
C. Difficile Infections
MRSA Bacteraemias
6
5
4
3
2
1
0
Key Targets
2
Cancer Waiting Times
Performance Indicators
Risk
Rating
Target
2009-10
Current
Position
Nov 2009
Year to Date
Position
Cancer: 14 day wait from urgent GP referral
MON09, CQC18
Low
93%
98.5%
(8 of 547)
98.5%
(72 of 4870)
Cancer: 31 days from diagnosis to treatment for all
cancers
MON10, CQC19.I
Low
96%
95.7%
(68 of 1576)
95.9%
(8 of 195)
Cancer: 31 days for subsequent cancer treatments Surgery
MON03.I, CQC19.II
Low
94%
96.7%
(1 of 30)
95.1%
(10 of 203)
Cancer: 31 days for subsequent cancer treatments –
Anti-Cancer Drugs
MON03.II, CQC19.III
Low
98%
99.7%
(1 of 288)
96.7%
(1 of 30)
Cancer: 62 days referral to treatment - GP Urgent
Referral
MON04.I, CQC20.I
Low
85%
86.4%
(12 of 88.5)
84.7%
(112 of 734)
Cancer: 62 days referral to treatment – Consultant
Screening Service
MON04.II, CQC20.II
Low
90%
93.3%
(1 of 15)
97.6%
(2 of 85)
Cancer: 62 days referral to treatment – Consultant
Upgrade
CQC20.III
Low
90%
66.7%
(3 of 9)
86.7%
(3 of 22.5)
Key Targets
2
Cancer Waiting Times
Cancer 31 Day Wait
For First Treatment
Cancer 62 Day Wait
For First Treatment
Key Targets
3
Emergency Department
Performance Indicators
Maximum waiting time of 4
hours in A&E from arrival to
admission, transfer or
discharge (bracketed figure is
RD&E activity only) MON07,
CQC04
Risk
Rating
Target
2008-09
Current
Year to Date
Position Nov
Position
2009
Very
Low
98%
97.7% 98.8%
(95.6%) (97.5%)
Key Targets
3
Emergency Department
Key Targets
4
Referral to Treatment Waiting Times
Risk
Rating
Target
2009-10
Current
Position
Nov 2009
Year to Date
Position
18-week maximum wait Admitted patients. MON05,
CQC17.III
Low
90%
92.3%
n/a
18-week maximum wait Non-admitted patients.
MON06,CQC17.IV
Low
95%
97.1%
n/a
18-week maximum wait by 2010 Admitted
orthopaedic patients. LOC3
Low
90%
70.6%
n/a
18-week maximum wait by 2010 Non-admitted
orthopaedic patients. LOC4
Low
95%
90.1%
n/a
13-week maximum wait by 2010 Admitted patients
(excl orthopaedics). LOC1
Low
90%
90.0%
n/a
13-week maximum wait by 2010 Non-admitted
patients (excl orthopaedics). LOC2
Low
95%
94.7%
n/a
Cancelled operations. CQC09
Med
0.80%
1.21%
2.57%
Performance Indicators
Key Targets
4
Referral to Treatment Waiting Times
Referral to Treatment for
Admitted Pathways
Referral to Treatment for
Non-Admitted Pathways
Current Capacity Pressures
 11 wards affected by Norovirus – 25 – 50 beds empty and
blocked
 Increase in trauma admissions due to adverse weather
conditions
 Increased number of medical outliers significantly reducing
surgical and orthopaedic bed capacity
 Short term difficulty due to weather conditions in transferring
patients home and to community beds
 Reduction in elective surgery impacting adversely on 18
week target
 Increase in A&E 4 hour breaches due to lack of bed
availability for admissions
Actions underway
 Additional cleaning staff provided to ensure wards
can be opened as quickly as possible
 Additional medical and nursing staff provided at
weekends and evenings for Emergency
Department, Trauma and Medical Wards
 Devon Health and Social Care Complex Care
Teams pulling patients out of RDE to home
Actions underway
 Additional bed and day case areas being opened
as an exception
 Extra elective capacity being provided - Vanguard
mobile theatre and beds, Nuffield, Plymouth
Independent Sector Treatment Centre
 Daily Eastern Devon multi-agency conference call
 Board rounds are being rolled out across the
wards
 Joint consultant/GP work to agree admission
criteria for community hospitals
Council of
Governors Meeting
Suzanne Tracey
Director of Finance and
Business Development
January 2010, Item 7
Finance Report – Month 8
 Year to Date £5.0m surplus approx £400k below
budget
 Clinical income broadly on plan but overspends
on expenditure budgets
 Significant overspend on non pay budgets –
action taken on authorisation levels
 Year end forecast still to achieve planned surplus
of £7m
 Financial Risk Rating Year to date 4
Capital Expenditure
 Annual planned expenditure £23.5m
 YTD plan £14.7m, expenditure £10m
 Forecast expenditure £18.6m
 Annual slippage £4.8m
– Pain Management
– Replacement of CT scanner
– Integrated minimal access theatre
– Order Communications and E Prescribing
Understanding slippage
 Savings on schemes
 Maintaining operational capacity
 Ensuring the scheme meets requirements
 Ensuring procurement meets regulations
 Further action – improvements to capital
planning process